Cases & Deals

MacroGenics maintains patent portfolio for biologics, immunotherapeutics and cancer targets

Clients MacroGenics, Inc.

Jones Day managed the patent portfolio and prosecuted key patents on behalf of MacroGenics, Inc. related to biologics, immunotherapeutics and cancer targets, particularly with respect to antibodies and other molecules that target Fc receptors.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.